EFPIA anticounterfeiting pilot success could see industry recognise parallel traders as part of supply chain
This article was originally published in Scrip
Executive Summary
Mass serialisation is a viable way of strengthening the supply chain and protecting against counterfeit medicines, a pilot launched by the European Federation of Pharmaceutical Industries and Associations (EFPIA) has shown. Furthermore, roll-out of such a verification system could prompt industry to recognise parallel traders as part of the supply chain.